Paxil Antitrust Suit Bounces Back To State Court

Law360, New York (February 4, 2008, 12:00 AM EST) -- A federal judge on Thursday sent an antitrust lawsuit against GlaxoSmithKline Plc, maker of the popular antidepressent Paxil, back to state court, allowing plaintiffs to proceed with claims they first brought more than two years ago.

A group of health care plans led by Blue Cross Blue Shield of Minnesota sued Glaxo in the U.S. District Court for the District of Minnesota in 2005, alleging that the company had used groundless patent lawsuits and false patent listings to keep generic competition out of the market for...
To view the full article, register now.